Logo image of DHCNL

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DHCNL - US25525P3055

17.62 USD
+0.08 (+0.46%)
Last: 11/21/2025, 8:23:24 PM
Fundamental Rating

2

Overall DHCNL gets a fundamental rating of 2 out of 10. We evaluated DHCNL against 128 industry peers in the Diversified REITs industry. DHCNL has a bad profitability rating. Also its financial health evaluation is rather negative. DHCNL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

DHCNL had negative earnings in the past year.
In the past year DHCNL had a positive cash flow from operations.
DHCNL had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DHCNL reported negative operating cash flow in multiple years.
DHCNL Yearly Net Income VS EBIT VS OCF VS FCFDHCNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.52%, DHCNL is doing worse than 86.72% of the companies in the same industry.
The Return On Equity of DHCNL (-20.85%) is worse than 84.38% of its industry peers.
Industry RankSector Rank
ROA -7.52%
ROE -20.85%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNL Yearly ROA, ROE, ROICDHCNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

DHCNL's Gross Margin of 17.58% is on the low side compared to the rest of the industry. DHCNL is outperformed by 94.53% of its industry peers.
DHCNL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DHCNL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNL Yearly Profit, Operating, Gross MarginsDHCNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

3

2. Health

2.1 Basic Checks

DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
DHCNL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DHCNL has been increased compared to 5 years ago.
Compared to 1 year ago, DHCNL has a worse debt to assets ratio.
DHCNL Yearly Shares OutstandingDHCNL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNL Yearly Total Debt VS Total AssetsDHCNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.32, we must say that DHCNL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DHCNL (0.32) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.61 is on the high side and indicates that DHCNL has dependencies on debt financing.
DHCNL has a worse Debt to Equity ratio (1.61) than 63.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC6.66%
DHCNL Yearly LT Debt VS Equity VS FCFDHCNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

DHCNL has a Current Ratio of 6.66. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
DHCNL's Current ratio of 6.66 is amongst the best of the industry. DHCNL outperforms 96.09% of its industry peers.
A Quick Ratio of 6.66 indicates that DHCNL has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.66, DHCNL belongs to the top of the industry, outperforming 96.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.66
Quick Ratio 6.66
DHCNL Yearly Current Assets VS Current LiabilitesDHCNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

DHCNL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.32%.
DHCNL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.10%.
The Revenue has been growing slightly by 7.53% on average over the past years.
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%

3.2 Future

Based on estimates for the next years, DHCNL will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.25% on average per year.
The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y20.64%
EPS Next 2Y17.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DHCNL Yearly Revenue VS EstimatesDHCNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNL Yearly EPS VS EstimatesDHCNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHCNL. In the last year negative earnings were reported.
Also next year DHCNL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNL Price Earnings VS Forward Price EarningsDHCNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DHCNL is valued more expensive than 92.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.3
DHCNL Per share dataDHCNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

DHCNL's earnings are expected to grow with 17.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.25%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

DHCNL has a yearly dividend return of 0.90%, which is pretty low.
Compared to an average industry Dividend Yield of 6.59, DHCNL's dividend is way lower than its industry peers. On top of this 91.41% of the companies listed in the same industry pay a better dividend than DHCNL!
With a Dividend Yield of 0.90, DHCNL pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.9%

5.2 History

The dividend of DHCNL decreases each year by -45.60%.
DHCNL has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years0
DHCNL Yearly Dividends per shareDHCNL Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

DHCNL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.74%
EPS Next 2Y17.25%
EPS Next 3YN/A
DHCNL Yearly Income VS Free CF VS DividendDHCNL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46

NASDAQ:DHCNL (11/21/2025, 8:23:24 PM)

17.62

+0.08 (+0.46%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners75.89%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.25B
Revenue(TTM)1.54B
Net Income(TTM)-352.11M
Analysts48
Price Target20.53 (16.52%)
Short Float %0%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield 0.9%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.74%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-14 2025-11-14 (0.390625)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.08%
Min EPS beat(2)-213.15%
Max EPS beat(2)-71.02%
EPS beat(4)1
Avg EPS beat(4)-46.14%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)2
Avg EPS beat(8)-24.79%
EPS beat(12)4
Avg EPS beat(12)-9.26%
EPS beat(16)4
Avg EPS beat(16)-20.93%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)-4.5%
PT rev (3m)-10.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.6%
EPS NY rev (3m)-27.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.77
P/FCF N/A
P/OCF 227.63
P/B 2.52
P/tB 2.52
EV/EBITDA 28.3
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.08
OCFY0.44%
SpS6.37
BVpS7
TBVpS7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.52%
ROE -20.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.58%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 11.41
Cap/Depr 65.29%
Cap/Sales 11.78%
Interest Coverage N/A
Cash Conversion 7.83%
Profit Quality N/A
Current Ratio 6.66
Quick Ratio 6.66
Altman-Z 0.32
F-Score6
WACC6.66%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
EPS Next Y20.64%
EPS Next 2Y17.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year377.31%
EBIT Next 3Y72.02%
EBIT Next 5YN/A
FCF growth 1Y38.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.8%
OCF growth 3YN/A
OCF growth 5Y-15.84%

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 / DHCNL FAQ

What is the ChartMill fundamental rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DHCNL.


What is the valuation status for DHCNL stock?

ChartMill assigns a valuation rating of 0 / 10 to DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL). This can be considered as Overvalued.


Can you provide the profitability details for DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46?

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) has a profitability rating of 1 / 10.


Can you provide the dividend sustainability for DHCNL stock?

The dividend rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is 1 / 10 and the dividend payout ratio is -2.74%.